Form 8.3 -PRIMARY HEALTH PROPERTIES PLC | 27-May-2025 | 14:41 | RNS |
Form 8.3 - Primary Health Properties PLC | 27-May-2025 | 14:16 | RNS |
Form 8.3 - Primary Health Properties Plc | 27-May-2025 | 14:15 | GlobeNewswire NA |
Form 8.3 - Assura PLC | 27-May-2025 | 14:15 | RNS |
Form 8.3 - Primary Health Properties PLC | 27-May-2025 | 13:55 | RNS |
Form 8.3 - Primary Health Properties plc | 27-May-2025 | 12:23 | RNS |
Form 8.3 - Primary Health Properties PLC | 27-May-2025 | 12:21 | RNS |
Form 8.3 - Primary Health Properties plc | 27-May-2025 | 12:07 | RNS |
Form 8.5 (EPT/RI) - Primary Health Properties Plc | 27-May-2025 | 12:00 | RNS |
Form 8.5 (EPT/RI)-Primary Health Properties plc | 27-May-2025 | 11:29 | RNS |
Form 8.3 - Primary Health Properties Plc | 27-May-2025 | 11:03 | RNS |
Form 8.5(EPT/NON-RI)-Primary Health Properties plc | 27-May-2025 | 10:53 | RNS |
Form 8.5 (EPT/RI)-Primary Health Properties plc | 27-May-2025 | 10:49 | RNS |
Form 8.5 (EPT/RI) - Primary Health Properties plc | 27-May-2025 | 10:10 | RNS |
Form 8.3 - Primary Health Properties plc | 27-May-2025 | 09:27 | RNS |
Currency | UK Pounds |
Share Price | 99.00p |
Change Today | 0.30p |
% Change | 0.30 % |
52 Week High | 103.50 |
52 Week Low | 86.15 |
Volume | 12,279,108 |
Shares Issued | 1,336.49m |
Market Cap | £1,323.13m |
Beta | 0.00 |
RiskGrade | 84 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 2 |
Buy | 1 |
Neutral | 3 |
Sell | 0 |
Strong Sell | 0 |
Total | 6 |
Latest | Previous | |
---|---|---|
Q2 | Q1 | |
Ex-Div | 27-Mar-25 | 09-Jan-25 |
Paid | 09-May-25 | 21-Feb-25 |
Amount | 1.77p | 1.77p |
Time | Volume / Share Price |
16:24 | 7 @ 99.05p |
16:05 | 1 @ 99.35p |
16:35 | 2,119,053 @ 99.00p |
16:35 | 43,926 @ 99.00p |
16:35 | 112,176 @ 99.00p |
CFO | Richard Howell |
CEO | Mark Davies |
You are here: research